Streptococcus pneumoniae bacteremia: comparison of incidence, epidemiology, and clinical outcome in a pre- and post-COVID-19 period
Abstract
Objectives: Streptococcus pneumoniae is a leading cause of severe bacterial infections, including pneumonia, meningitis, and bacteremia. We aimed to evaluate the differences in clinical, epidemiological and outcome manifestations of patients admitted with S. pneumoniae bacteremia (SPB) in the pre- and post-COVID-19 period.
Methods: The study analyzed all patients admitted in Province of Modena, Italy, during two time-periods: pre-COVID-19 (Jan 2018- Feb 2020) and post-COVID-19 (Mar 2020- Jun 2022) period. The data were compared using univariate and multivariate analysis.
Results: A total of 150 patients with SPB were included, 109 and 41 patients in the pre- and post-COVID-19, respectively. We observed a decrease in SPB incidence from March 2020, after the implementation of the restrictive measures for the COVID-19 pandemic, and a new increase since Jun 2021, when lockdown measures were fully lifted. SPB was associated with pneumonia in 128 patients (85.3%), meningitis in 25 (16.7%) and otitis-mastoiditis in 14 (9.3%). The proportion of patients presenting with multi-lobar pneumonia significantly increased during the post-COVID-19 period (39.0% vs. 16.5%, p = 0.008). Thirty-day mortality rate resulted higher in the post-COVID-19 period (24.4% vs. 11.9%, p = 0.075), and multivariate analysis identified an age ≥ 80 years (OR 4.45, 95% CI 1.12-17.61, p = 0.033), multi-lobar pneumonia (OR 4.34, 95% CI 1.56-12.07, p = 0.005), and central nervous system disease (OR 3.63, 95% CI…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 150 participants or records.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.